GB8518301D0 — Hydrodynamically explosive systems
Assigned to Fujisawa Pharmaceutical Co Ltd · Expires 1985-08-29 · 41y expired
What this patent protects
Time-Controlled Explosion Systems comprising drug, swelling agent and water-insoluble coating material characterized in that drug release is caused by the explosion of membrane after a definite time period, and method for preparing it.
USPTO Abstract
Time-Controlled Explosion Systems comprising drug, swelling agent and water-insoluble coating material characterized in that drug release is caused by the explosion of membrane after a definite time period, and method for preparing it.
Drugs covered by this patent
- Imbruvica (ibrutinib) · AbbVie
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.